The biliary stents market size has grown strongly in recent years. It will grow from $0.5 billion in 2025 to $0.53 billion in 2026 at a compound annual growth rate (CAGR) of 6%. The growth in the historic period can be attributed to limited stent material variety, reliance on traditional plastic stents, increasing incidence of biliary obstructions, growing hospital-based procedures, lack of advanced endoscopic equipment.
The biliary stents market size is expected to see strong growth in the next few years. It will grow to $0.66 billion in 2030 at a compound annual growth rate (CAGR) of 5.6%. The growth in the forecast period can be attributed to development of covered and partially covered metal stents, rising demand for biodegradable polymer stents, expansion of minimally invasive surgical procedures, increasing awareness of stent-related complications, integration of imaging and smart stent technologies. Major trends in the forecast period include increasing use of self-expandable metal stents (sems), rising adoption of biodegradable polymer stents, growth in endoscopic and minimally invasive procedures, expansion of biliary stent applications in pancreatic and gallstone treatments, enhanced focus on stent safety and patient outcomes.
The rising incidence of pancreatic cancer is expected to propel the growth of the biliary stents market going forward. Pancreatic cancer is a type of cancer that originates in the tissues of the pancreas, an organ crucial for digestion and blood sugar regulation. The incidence of pancreatic cancer is increasing due to an aging population and the growing prevalence of risk factors such as obesity, diabetes, and smoking. Biliary stents aid pancreatic cancer care by relieving bile duct obstructions, improving liver function, and reducing jaundice. They enhance patient comfort by promoting bile flow, supporting ongoing cancer treatment, and improving quality of life. For instance, in February 2025, according to Cancer Australia, an Australia-based government agency, there were 4,641 new pancreatic cancer cases in 2024, with 2,414 in males and 2,227 in females. Therefore, the rising incidence of pancreatic cancer is driving the growth of the biliary stents market.
Major companies operating in the biliary stents market are focusing on developing advanced products, such as drug-eluting stents, to improve patient outcomes, increase durability, and reduce complications like restenosis. Drug-eluting stents are specialized biliary stents coated with medication that is slowly released to prevent tissue overgrowth and blockages in the bile ducts. For instance, in July 2024, CGBIO, a South Korea-based medical device company, received Pharmaceuticals and Medical Devices Agency (PMDA) approval in Japan for biliary ARISTENT. This stent is designed to treat bile duct blockages and features a patented ‘HOOK & CROSS’ structure for enhanced flexibility and long-term patency. It adapts to the bile duct’s anatomy, reducing migration risk and improving patient comfort, while its advanced drug-eluting coating minimizes inflammation and prolongs stent patency, offering an effective solution for biliary obstructions.
In January 2024, Olympus Corporation, a Japan-based medical technology company, acquired Taewoong Medical Co. Ltd. for \$370 million. Through this acquisition, Olympus aims to strengthen its global endoscopic device portfolio by incorporating Taewoong’s metallic stents, including biliary stents, enhancing its capabilities in gastrointestinal treatments. Taewoong Medical Co. Ltd. is a South Korea-based company specializing in self-expandable metallic stents, including biliary stents.
Major companies operating in the biliary stents market are Cardinal Health Inc., Abbott Laboratories, Medtronic plc, Becton Dickinson & Company, Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Smith & Nephew Plc., W. L. Gore & Associates Inc., Nipro Corporation, Teleflex Incorporated, Cook Group, NuVasive Inc., Merit Medical Systems Inc., CONMED Corporation, Brainlab, Bard Peripheral Vascular Inc., Argon Medical Devices Inc., B Braun Melsungen AG, M.I Tech.
North America was the largest region in the biliary stents market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biliary stents market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the biliary stents market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the biliary stents market by increasing the cost of imported metals, polymers, and medical-grade plastics used in stent manufacturing. Segments such as metal stents and biodegradable polymer stents are most affected, particularly in Asia-Pacific regions like China and India, which are key manufacturing hubs. This has resulted in higher production costs and adjustments in supply chains. On the positive side, tariffs are encouraging domestic manufacturing, adoption of alternative materials, and investment in localized production capabilities.
The biliary stents market research report is one of a series of new reports that provides biliary stents market statistics, including biliary stents industry global market size, regional shares, competitors with a biliary stents market share, detailed biliary stents market segments, market trends and opportunities, and any further data you may need to thrive in the biliary stents industry. This biliary stents market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Biliary stents are small, tube-like devices inserted into the bile ducts to maintain their openness and ensure proper bile flow from the liver to the intestines. They are commonly used to relieve blockages caused by conditions such as tumors, gallstones, or inflammation. Biliary stents help prevent or reduce bile duct obstruction, alleviating symptoms like jaundice and minimizing the risk of liver damage.
The key types of biliary stents include metal, polymer, and plastic stents. Metal stents are tubular devices made from alloys such as stainless steel, nitinol (nickel-titanium), cobalt-chromium, and platinum-chromium. They are available in different designs, including single, double, and triple stents, and are used in procedures like endoscopic retrograde cholangiopancreatography and percutaneous transhepatic cholangiography. These stents are applied in managing biliopancreatic leakages, pancreatic cancer, benign biliary strictures, gallstones, and other conditions, serving end users such as hospitals, ambulatory surgical centers, specialty clinics, and others.
The biliary stents market consists of sales of biliary stent systems, single-use and reusable devices, bioabsorbable stents, and stent delivery systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The biliary stents market size is expected to see strong growth in the next few years. It will grow to $0.66 billion in 2030 at a compound annual growth rate (CAGR) of 5.6%. The growth in the forecast period can be attributed to development of covered and partially covered metal stents, rising demand for biodegradable polymer stents, expansion of minimally invasive surgical procedures, increasing awareness of stent-related complications, integration of imaging and smart stent technologies. Major trends in the forecast period include increasing use of self-expandable metal stents (sems), rising adoption of biodegradable polymer stents, growth in endoscopic and minimally invasive procedures, expansion of biliary stent applications in pancreatic and gallstone treatments, enhanced focus on stent safety and patient outcomes.
The rising incidence of pancreatic cancer is expected to propel the growth of the biliary stents market going forward. Pancreatic cancer is a type of cancer that originates in the tissues of the pancreas, an organ crucial for digestion and blood sugar regulation. The incidence of pancreatic cancer is increasing due to an aging population and the growing prevalence of risk factors such as obesity, diabetes, and smoking. Biliary stents aid pancreatic cancer care by relieving bile duct obstructions, improving liver function, and reducing jaundice. They enhance patient comfort by promoting bile flow, supporting ongoing cancer treatment, and improving quality of life. For instance, in February 2025, according to Cancer Australia, an Australia-based government agency, there were 4,641 new pancreatic cancer cases in 2024, with 2,414 in males and 2,227 in females. Therefore, the rising incidence of pancreatic cancer is driving the growth of the biliary stents market.
Major companies operating in the biliary stents market are focusing on developing advanced products, such as drug-eluting stents, to improve patient outcomes, increase durability, and reduce complications like restenosis. Drug-eluting stents are specialized biliary stents coated with medication that is slowly released to prevent tissue overgrowth and blockages in the bile ducts. For instance, in July 2024, CGBIO, a South Korea-based medical device company, received Pharmaceuticals and Medical Devices Agency (PMDA) approval in Japan for biliary ARISTENT. This stent is designed to treat bile duct blockages and features a patented ‘HOOK & CROSS’ structure for enhanced flexibility and long-term patency. It adapts to the bile duct’s anatomy, reducing migration risk and improving patient comfort, while its advanced drug-eluting coating minimizes inflammation and prolongs stent patency, offering an effective solution for biliary obstructions.
In January 2024, Olympus Corporation, a Japan-based medical technology company, acquired Taewoong Medical Co. Ltd. for \$370 million. Through this acquisition, Olympus aims to strengthen its global endoscopic device portfolio by incorporating Taewoong’s metallic stents, including biliary stents, enhancing its capabilities in gastrointestinal treatments. Taewoong Medical Co. Ltd. is a South Korea-based company specializing in self-expandable metallic stents, including biliary stents.
Major companies operating in the biliary stents market are Cardinal Health Inc., Abbott Laboratories, Medtronic plc, Becton Dickinson & Company, Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Smith & Nephew Plc., W. L. Gore & Associates Inc., Nipro Corporation, Teleflex Incorporated, Cook Group, NuVasive Inc., Merit Medical Systems Inc., CONMED Corporation, Brainlab, Bard Peripheral Vascular Inc., Argon Medical Devices Inc., B Braun Melsungen AG, M.I Tech.
North America was the largest region in the biliary stents market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biliary stents market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the biliary stents market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the biliary stents market by increasing the cost of imported metals, polymers, and medical-grade plastics used in stent manufacturing. Segments such as metal stents and biodegradable polymer stents are most affected, particularly in Asia-Pacific regions like China and India, which are key manufacturing hubs. This has resulted in higher production costs and adjustments in supply chains. On the positive side, tariffs are encouraging domestic manufacturing, adoption of alternative materials, and investment in localized production capabilities.
The biliary stents market research report is one of a series of new reports that provides biliary stents market statistics, including biliary stents industry global market size, regional shares, competitors with a biliary stents market share, detailed biliary stents market segments, market trends and opportunities, and any further data you may need to thrive in the biliary stents industry. This biliary stents market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Biliary stents are small, tube-like devices inserted into the bile ducts to maintain their openness and ensure proper bile flow from the liver to the intestines. They are commonly used to relieve blockages caused by conditions such as tumors, gallstones, or inflammation. Biliary stents help prevent or reduce bile duct obstruction, alleviating symptoms like jaundice and minimizing the risk of liver damage.
The key types of biliary stents include metal, polymer, and plastic stents. Metal stents are tubular devices made from alloys such as stainless steel, nitinol (nickel-titanium), cobalt-chromium, and platinum-chromium. They are available in different designs, including single, double, and triple stents, and are used in procedures like endoscopic retrograde cholangiopancreatography and percutaneous transhepatic cholangiography. These stents are applied in managing biliopancreatic leakages, pancreatic cancer, benign biliary strictures, gallstones, and other conditions, serving end users such as hospitals, ambulatory surgical centers, specialty clinics, and others.
The biliary stents market consists of sales of biliary stent systems, single-use and reusable devices, bioabsorbable stents, and stent delivery systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Biliary Stents Market Characteristics
3. Biliary Stents Market Supply Chain Analysis
4. Global Biliary Stents Market Trends and Strategies
5. Biliary Stents Market Analysis of End Use Industries
7. Global Biliary Stents Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Biliary Stents Total Addressable Market (TAM) Analysis for the Market
9. Biliary Stents Market Segmentation
10. Biliary Stents Market Regional and Country Analysis
11. Asia-Pacific Biliary Stents Market
12. China Biliary Stents Market
13. India Biliary Stents Market
14. Japan Biliary Stents Market
15. Australia Biliary Stents Market
16. Indonesia Biliary Stents Market
17. South Korea Biliary Stents Market
18. Taiwan Biliary Stents Market
19. South East Asia Biliary Stents Market
20. Western Europe Biliary Stents Market
21. UK Biliary Stents Market
22. Germany Biliary Stents Market
23. France Biliary Stents Market
24. Italy Biliary Stents Market
25. Spain Biliary Stents Market
26. Eastern Europe Biliary Stents Market
27. Russia Biliary Stents Market
28. North America Biliary Stents Market
29. USA Biliary Stents Market
30. Canada Biliary Stents Market
31. South America Biliary Stents Market
32. Brazil Biliary Stents Market
33. Middle East Biliary Stents Market
34. Africa Biliary Stents Market
36. Biliary Stents Market Competitive Landscape and Company Profiles
37. Biliary Stents Market Other Major and Innovative Companies
40. Biliary Stents Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Biliary Stents Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses biliary stents market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for biliary stents? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The biliary stents market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Metal; Polymer; Plastic2) By Design: Single Stent; Double Stent; Triple Stent
3) By Procedure: Endoscopic Retrograde Cholangiopancreatography; Percutaneous Transhepatic Cholangiography
4) By Application: Biliopancreatic Leakages; Pancreatic Cancer; Benign Biliary Structures; Gallstones; Other Applications
5) By End User: Hospitals; Ambulatory Surgical Centers; Specialty clinics; Other End-Users
Subsegments:
1) By Metal: Self-Expandable Metal Stents (SEMS); Covered Metal Stents; Uncovered Metal Stents; Partially Covered Metal Stents2) By Polymer: Biodegradable Polymer Stents; Non-Biodegradable Polymer Stents
3) By Plastic: Straight Plastic Stents; Double Pigtail Plastic Stents; Multiple Side Hole Stents; Teflon Stents; Polyurethane Stents
Companies Mentioned: Cardinal Health Inc.; Abbott Laboratories; Medtronic plc; Becton Dickinson & Company; Stryker Corporation; Boston Scientific Corporation; Olympus Corporation; Smith & Nephew Plc.; W. L. Gore & Associates Inc.; Nipro Corporation; Teleflex Incorporated; Cook Group; NuVasive Inc.; Merit Medical Systems Inc.; CONMED Corporation; Brainlab; Bard Peripheral Vascular Inc.; Argon Medical Devices Inc.; B Braun Melsungen AG; M.I Tech
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Biliary Stents market report include:- Cardinal Health Inc.
- Abbott Laboratories
- Medtronic plc
- Becton Dickinson & Company
- Stryker Corporation
- Boston Scientific Corporation
- Olympus Corporation
- Smith & Nephew Plc.
- W. L. Gore & Associates Inc.
- Nipro Corporation
- Teleflex Incorporated
- Cook Group
- NuVasive Inc.
- Merit Medical Systems Inc.
- CONMED Corporation
- Brainlab
- Bard Peripheral Vascular Inc.
- Argon Medical Devices Inc.
- B Braun Melsungen AG
- M.I Tech
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 0.53 Billion |
| Forecasted Market Value ( USD | $ 0.66 Billion |
| Compound Annual Growth Rate | 5.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
